Article
The Role of Beta-D-Glucan in the Diagnosis of Invasive Fungal Infections
August 1, 2022
Case A 77-year-old woman with malnutrition, who is undergoing chemotherapy for small cell lung cancer, is being treated with intravenous ceftriaxone and vancomycin through a peripherally inserted...
Article
New HHS Guidance for Increasing Number of Buprenorphine Clinicians Who Can Treat OUD
June 1, 2022
Does your state allow it? The ongoing opioid epidemic The U.S. hit a grim milestone of more than 100,000 drug overdose deaths,1 most opioid-involved, in the 12 months ending April 2021. This...
Article
Alcohol Withdrawal: Looking Beyond Benzodiazepines
June 1, 2022
Case Mr. Smith is a 48-year-old man with alcohol use disorder (AUD) and compensated cirrhosis who presented to the emergency department with alcohol withdrawal. He had been consuming one pint of...
![1]()
News
New data on rare myocarditis after COVID-19 vaccination
December 8, 2021
Most adolescents and young adults recover quickly from the rare complication of myocarditis following mRNA COVID-19 vaccination, a new study shows.
![1]()
News
Apixaban outmatches rivaroxaban for VTE in study
December 6, 2021
These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.
![1]()
News
SGLT2 inhibitor use tied to fewer atrial arrhythmias
December 2, 2021
A prospective study of nearly 14,000 patients who received an implantable cardiac device suggests that SGLT2-inhibitor treatment cuts atrial arrhythmias.
News
Merck’s COVID-19 pill may be less effective than first hoped
November 30, 2021
The new results seem to put molnupiravir far below the effectiveness of existing treatments.
News
Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
November 19, 2021
Study shows empagliflozin led to a consistent, significant relative risk reduction compared with placebo in the primary endpoint.
![1]()
News
Empagliflozin a winner in challenging arena of stabilized acute HF
November 19, 2021
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of their ejection fraction, says an expert observer.
News
Regeneron’s antibody drug shows protection against COVID-19 for up to 8 months
November 10, 2021
Such immunity is particularly important for immunocompromised people and those not responding to vaccines.
